Citation Impact
Citing Papers
Recent Molecular Genetic Explorations of Caenorhabditis elegans MicroRNAs
2018 StandoutNobel
International consensus guidance for management of myasthenia gravis
2016 Standout
The C. elegans heterochronic gene lin-28 coordinates the timing of hypodermal and somatic gonadal programs for hermaphrodite reproductive system morphogenesis
2019 StandoutNobel
Concise Review: LIN28/let-7 Signaling, a Critical Double-Negative Feedback Loop During Pluripotency, Reprogramming, and Tumorigenicity
2017
MicroRNA-mediated gene regulation and the resilience of multicellular animals
2024 StandoutNobel
Neuromuscular Junction Formation in Tissue-Engineered Skeletal Muscle Augments Contractile Function and Improves Cytoskeletal Organization
2015
Myasthenia gravis: a clinical-immunological update
2015
Treatment of MuSK-Associated Myasthenia Gravis
2014
Modulation of the W748S mutation in DNA polymerase γ by the E1143G polymorphismin mitochondrial disorders
2006
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
2016 Standout
Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis
2017
Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia Gravis
2011
Myasthenia Gravis
2016 Standout
Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap
2016
Voltage gated calcium channel antibody-related neurological diseases
2015
Immunostimulatory properties and antitumor activities of glucans
2013
Decoding ALS: from genes to mechanism
2016 StandoutNature
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Mechanism of Neuromuscular Dysfunction in Krabbe Disease
2015
Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase
2013
Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity
2018
Structure–function relationships of immunostimulatory polysaccharides: A review
2015 Standout
The Role of Muscle microRNAs in Repairing the Neuromuscular Junction
2014
Myasthenia gravis
2019 Standout
Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases
2015
Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
2014
Autoantibodies to Agrin in Myasthenia Gravis Patients
2014
MuSK Frizzled-Like Domain Is Critical for Mammalian Neuromuscular Junction Formation and Maintenance
2015
Pathophysiology and immunological profile of myasthenia gravis and its subgroups
2017
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
2012
Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis
2012
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Guidelines for treatment of autoimmune neuromuscular transmission disorders
2010
Myasthenia gravis and the neuromuscular junction
2013
Update on juvenile myasthenia gravis
2013
MuSK-antibody positive myasthenia gravis: Questions from the clinic
2008
Modulation of Inflammation-Induced Tolerance in Cancer
2020
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Thymus involvement in early‐onset myasthenia gravis
2017
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
LIN‐28 balances longevity and germline stem cell number in Caenorhabditis elegans through let‐7/AKT/DAF‐16 axis
2016
Electrophysiological profile of the patients with MuSK positive myasthenia gravis
2014
Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing
2013
Anti-MuSK autoantibodies block binding of collagen Q to MuSK
2011
Myasthenia and the neuromuscular junction
2012
Current and emerging therapies for the treatment of myasthenia gravis
2011
Repetitive nerve stimulation and single‐fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert–Eaton myasthenic syndrome: Review of recent literature
2015
Acetylcholinesterase inhibitor treatment for myasthenia gravis
2014
Anti-agrin autoantibodies in myasthenia gravis
2014
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
2011
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Antibodies against low-density lipoprotein receptor–related protein 4 induce myasthenia gravis
2013
Works of Anna Rostedt Punga being referenced
Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients
2017
Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis
2018
Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice
2011
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes
2006
Monozygous twins with neuromuscular transmission defects at opposite sides of the motor endplate
2008
MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity
2011
Acetylcholinesterase inhibitors in MG: To be or not to be?
2009
β-glucans reduce LDL cholesterol in patients with myasthenia gravis
2012
Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis
2007
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis
2014
Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody
2006
Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum
2019
Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS
2012
Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients
2015
Disease specific enrichment of circulating let-7 family microRNA in MuSK + myasthenia gravis
2016
Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis
2016
Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseases
2012
Circulating microRNAs as potential biomarkers in myasthenia gravis patients
2017
Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study
2016
Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D 3: a pilot study
2012
Circulating miRNA s in myasthenia gravis: miR‐150‐5p as a new potential biomarker
2013